U.S. Markets open in 7 hrs 7 mins

Adamis (ADMP) Shows Strength: Stock Gains 6.7% in Session

Zacks Equity Research

Adamis Pharmaceuticals Corporation ADMP was a big mover last session, as its shares rose almost 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.20 to $3.75 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Adamis currently carries a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%.

Adamis Pharmaceuticals Corporation Price

 

Adamis Pharmaceuticals Corporation Price | Adamis Pharmaceuticals Corporation Quote

Another favorably ranked stock is BioCryst Pharmaceuticals, Inc. BCRX, carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is ADMP going up? Or down? Predict to see what others think: Up or Down

8 Stocks with Huge Profit Potential

Just released: Driverless Cars: Your Roadmap to Mega-Profits Today. In this latest Special Report, Zacks’ Aggressive Growth Strategist Brian Bolan explores a full-blown technological breakthrough in the making – autonomous cars. He also spotlights 8 stocks with tremendous gain potential to feed off this phenomenon. Click to see the stocks right now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BioCryst Pharmaceuticals, Inc. (BCRX): Free Stock Analysis Report
 
Adamis Pharmaceuticals Corporation (ADMP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research